A detailed history of Raleigh Capital Management Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 5 shares of DGX stock, worth $685. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$685
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$125.91 - $144.34 $629 - $721
5 New
5 $0
Q4 2023

Feb 21, 2024

SELL
$120.62 - $141.12 $3,980 - $4,656
-33 Reduced 97.06%
1 $0
Q3 2023

Dec 06, 2023

SELL
$121.86 - $144.92 $243 - $289
-2 Reduced 5.56%
34 $4,000
Q2 2023

Jul 25, 2023

SELL
$130.56 - $146.84 $20,497 - $23,053
-157 Reduced 81.35%
36 $5,000
Q1 2023

May 22, 2023

BUY
$131.53 - $155.76 $4,866 - $5,763
37 Added 23.72%
193 $27,000
Q4 2022

Feb 07, 2023

BUY
$123.31 - $157.26 $13,934 - $17,770
113 Added 262.79%
156 $24,000
Q3 2022

Nov 09, 2022

BUY
$121.77 - $141.1 $5,236 - $6,067
43 New
43 $5,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.